Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription Articles published in Virology Retrieve available abstracts of 79 articles: HTML format

Single Articles

June 2026
1. WANG Z, Wongnak R, Oba M, Mizutani T, et al
   Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice.
   Virology. 2026;619:110894.
   PubMed     Abstract available
   
   
   April 2026
2. BUDE SA, Zhao Z, Zhang J, Lu Z, et al
   Expression of pseudorabies virus glycoproteins E and B based on vaccinia virus.
   Virology. 2026;620:110916.
   PubMed     Abstract available
   
   
   
3. ULLAH SHAH A, Rafique S, Peddireddi L, Wood B, et al
   Genomic characterization of some infectious laryngotracheitis virus (ILTV) field isolates from vaccinated chicken farms reveals evidence of vaccine-related genetic drift.
   Virology. 2026;620:110900.
   PubMed     Abstract available
   
   
   
4. SHARMA S, Thivierge B, Liu Q
   A bivalent subunit vaccine elicits robust immune responses and neutralizing antibodies against genogroup 1b and 2b porcine epidemic diarrhea viruses.
   Virology. 2026;617:110824.
   PubMed     Abstract available
   
   
   
5. WUBSHET AK, Ding Y, Zhou L, Wang Y, et al
   Development of baculovirus-derived bovine parvovirus VP2based chimeric virus-like particles co-displaying SAT2 FMDV VP1 B- and T-cell epitopes and evaluation of humoral and cellular immune responses in BALB/c mice.
   Virology. 2026;617:110812.
   PubMed     Abstract available
   
   
   
6. LIU H, Ma Y, Hou F, Teng Z, et al
   Combination immunization with mRNAs encoding PRRSV antigens enhances immune responses and confers protective immunity against highly pathogenic PRRSV in piglets.
   Virology. 2026;617:110810.
   PubMed     Abstract available
   
   
   March 2026
7. RAMUTH M, Sonoo J, Pyndiah N, Rughooputh S, et al
   Epidemiology of influenza A and B viruses in Mauritius over an 8-year period, 2009-2016.
   Virology. 2026;619:110892.
   PubMed     Abstract available
   
   
   
8. MORALES RUIZ S, Wang Z, Miura T, Shida H, et al
   Potent protective ability of vaccinia virus LC16 strains lacking the B5R gene.
   Virology. 2026;619:110888.
   PubMed     Abstract available
   
   
   
9. LIU R, Patterson L, Yeasmin M, Kim KH, et al
   Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
   Virology. 2026;619:110884.
   PubMed     Abstract available
   
   
   
10. CHUNG YJ, Oh HS, Kim SO, Hong SP, et al
    Protective efficacy of GMAI-02, a cDNA-derived inactivated hepatitis A vaccine, against HM175/mp7 challenge in interferon-receptor-deficient mice.
    Virology. 2026;619:110883.
    PubMed     Abstract available
    
    
    
11. SWIERKOT J, Tyczynska KM, Siemaszko J, Madej M, et al
    The association of selected genetic polymorphisms with adverse events following COVID-19 vaccination: a single-centre prospective observational cohort study.
    Virology. 2026;619:110876.
    PubMed     Abstract available
    
    
    February 2026
12. LI Z, Zhao M, Zhang G, Cheng J, et al
    Spike 1 trimer subunit vaccines against porcine epidemic diarrhea virus effectively induce protective immunity challenge in piglets.
    Virology. 2026;617:110823.
    PubMed     Abstract available
    
    
    
13. LI J, Yang Q, Yang Z, Huyan Y, et al
    Structural and immunogenic characteristics of goose parvovirus virus-like particles.
    Virology. 2026;614:110727.
    PubMed     Abstract available
    
    
    January 2026
14. VADIBELER S, Mandal H, Ooi S, Atiya N, et al
    Barriers to dengue vaccine coverage in low- and middle-income countries (LMICs).
    Virology. 2026;617:110821.
    PubMed     Abstract available
    
    
    
15. THOMAS MH, Carlock MA, Ross TM
    Adjuvants enhance protective antibodies against seasonal influenza viruses following a single vaccination of Fluzone.
    Virology. 2026;616:110787.
    PubMed     Abstract available
    
    
    December 2025
16. NGUYEN CT, Nakayama M, Yasui F, Ishigaki H, et al
    Vaccinia virus-based SARS-CoV-2 vaccine prevents lung immunopathology without antibody-dependent enhancement in female rhesus macaques.
    Virology. 2025;616:110778.
    PubMed     Abstract available
    
    
    November 2025
17. LONG J, Liu K, Chen Y, Wang X, et al
    Attenuation of a contemporary Chinese PRRSV-1 strain via serial cell passage and evaluation of its protective efficacy as a modified live virus vaccine candidate.
    Virology. 2025;615:110746.
    PubMed     Abstract available
    
    
    
18. BRICE DC, Andreev K, Miller L, Patton C, et al
    Immunogenicity and efficacy of commercial poultry avian influenza vaccines against HPAI A(H5N1) clade 2.3.4.4b viruses in Mexico.
    Virology. 2025;615:110765.
    PubMed     Abstract available
    
    
    September 2025
19. ELHAZAZ FERNANDEZ A, Abidi S, Mahl K, Scheffler D, et al
    A chiropteran factor of innate immunity can be recruited for rapid rescue and amplification of recombinant modified vaccinia Ankara (MVA).
    Virology. 2025;612:110698.
    PubMed     Abstract available
    
    
    
20. KIM KH, Hwang HS, Lee Y, Jung YJ, et al
    Interferon-gamma receptor signaling is critical for balanced immune activation and protection against influenza after vaccination.
    Virology. 2025;612:110674.
    PubMed     Abstract available
    
    
    August 2025
21. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    PubMed     Abstract available
    
    
    
22. BABA S, Koyama T, Komatsu D, Uchino T, et al
    Development of an effective DNA vaccine against ayu atypical cellular gill disease using draft genome information of the causative agent, Plecoglossus altivelis poxvirus.
    Virology. 2025;612:110671.
    PubMed     Abstract available
    
    
    
23. ZENG F, Liu Q, Wang X, Zhong P, et al
    Immunoinformatics design and experimental expression of a multi-epitope vaccine simultaneously targeting AAV2 and HAdV-F41 against acute hepatitis of unknown etiology.
    Virology. 2025;611:110653.
    PubMed     Abstract available
    
    
    
24. ZHANG S, Liu G, Guo A, Chen Y, et al
    Maternal antibody transfer efficiency: The impact of M. bovis-BoHV-1 combined vaccine.
    Virology. 2025;611:110656.
    PubMed     Abstract available
    
    
    June 2025
25. YIN W, Chang C, Zhu Y, Ma F, et al
    Construction of vitamin E-based oil-in-water nano-emulsion adjuvant enhances immunogenicity of inactivated pseudorabies virus vaccine.
    Virology. 2025;610:110616.
    PubMed     Abstract available
    
    
    
26. PASQUALE S, Moscara L, Palmieri C, Martinelli A, et al
    Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024.
    Virology. 2025;610:110613.
    PubMed     Abstract available
    
    
    
27. FENG S, Huang M, Quan Y, Sun L, et al
    The spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-dimer mRNA vaccine against SARS-CoV-2 variants.
    Virology. 2025;610:110612.
    PubMed     Abstract available
    
    
    
28. YANG H, Song W, Li Z, Zhu Z, et al
    Genomic characteristics and pathogenicity of three newly isolated NADC34-like PRRSV strains in China and evaluation of one strain for inactivated vaccine candidate.
    Virology. 2025;610:110605.
    PubMed     Abstract available
    
    
    
29. TABYNOV K, Kuanyshbek A, Zharmambet K, Yelchibayeva L, et al
    Evaluation of commercial vaccines for efficacy and transmission control against the emergent H5N8 (clade 2.3.4.4b) avian influenza virus in Kazakhstan.
    Virology. 2025;610:110601.
    PubMed     Abstract available
    
    
    
30. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
    Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
    Virology. 2025;607:110512.
    PubMed     Abstract available
    
    
    May 2025
31. SONI S, Kennedy MA, Wang D, Li F, et al
    The role and implication of rotavirus VP8 * in viral infection and vaccine development.
    Virology. 2025;609:110563.
    PubMed     Abstract available
    
    
    
32. CHOI KY, McGregor A
    The guinea pig as a relevant preclinical model in the rat race for a vaccine against congenital cytomegalovirus infection.
    Virology. 2025;610:110560.
    PubMed     Abstract available
    
    
    
33. ISHIGAKI H, Itoh Y
    Translational research on pandemic virus infection using nonhuman primate models.
    Virology. 2025;606:110511.
    PubMed     Abstract available
    
    
    April 2025
34. XU J, Zhang B, Wang B, Ye Z, et al
    The PB subunit vaccine evokes immune response against fox encephalitis.
    Virology. 2025;609:110561.
    PubMed     Abstract available
    
    
    
35. JIANG FY, Xia JY, Jia YJ, Zhu B, et al
    Multi-epitope microsphere vaccine modified immunological efficacy against LMBV in largemouth bass (Micropterus salmoides).
    Virology. 2025;608:110553.
    PubMed     Abstract available
    
    
    
36. SUZUKI Y
    Application of reverse genetics system to Chikungunya virus study.
    Virology. 2025;605:110465.
    PubMed     Abstract available
    
    
    March 2025
37. RAHA JR, Kim KH, Tien Le CT, Bhatnagar N, et al
    A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
    Virology. 2025;606:110510.
    PubMed     Abstract available
    
    
    
38. BANGA NDZOUBOUKOU JL, Kamara AA, Ullah N, Lei Q, et al
    A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
    Virology. 2025;606:110509.
    PubMed     Abstract available
    
    
    
39. ZENG L, Bai J, Huang J, Huang S, et al
    Construction and preliminary immunological evaluation of EV-G replicon expressing PEDV-COE-N region.
    Virology. 2025;604:110436.
    PubMed     Abstract available
    
    
    January 2025
40. KORNUTA CA, Bidart JE, Soria I, Quattrocchi V, et al
    Galectin-8 and GEL01 as potential adjuvants to enhance the immune response induced by a DNA vaccine against bovine alphaherpesvirus Type-1.
    Virology. 2025;604:110402.
    PubMed     Abstract available
    
    
    
41. FRAGOSO-SAAVEDRA M, Liu Q
    Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies.
    Virology. 2025;604:110412.
    PubMed     Abstract available
    
    
    
42. WANG N, Yuan C, Wang Z, Yu C, et al
    An effective antiviral strategy based on silence of susceptibility genes through cucumber mosaic virus (CMV) attenuated vaccine vector.
    Virology. 2025;603:110396.
    PubMed     Abstract available
    
    
    
43. ZHAO Y, Li W, Xu L, Tao Z, et al
    Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2.
    Virology. 2025;603:110404.
    PubMed     Abstract available
    
    
    
44. SAHA A, Choudhary S, Walia P, Kumar P, et al
    Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction.
    Virology. 2025;604:110394.
    PubMed     Abstract available
    
    
    
45. SULTANA R, Stahelin RV
    Strengths and limitations of SARS-CoV-2 virus-like particle systems.
    Virology. 2025;601:110285.
    PubMed     Abstract available
    
    
    
46. YANG M, Jiao Y, Yan Y, Fu Z, et al
    Recombinant feline herpesvirus-1 (FHV-1) expressing granulocyte colony-stimulating factor (G-CSF) exhibits enhanced protective efficacy in felines.
    Virology. 2025;601:110282.
    PubMed     Abstract available
    
    
    
47. HU W, Tang D, Zeng Z, Wang B, et al
    Research progress on the molecular mechanism of immune escape of porcine reproductive and respiratory syndrome virus.
    Virology. 2025;602:110298.
    PubMed     Abstract available
    
    
    December 2024
48. CALDERON-PEREZ B, Nunez-Munoz LA, Trejo-Ayala LL, Rosales-Garcia VH, et al
    Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants.
    Virology. 2024;603:110380.
    PubMed     Abstract available
    
    
    
49. PENG Y, Luo Y, Pan L, Hou Y, et al
    Immunogenicity analysis based on VP1 and VP2 proteins of bovine enterovirus.
    Virology. 2024;600:110260.
    PubMed     Abstract available
    
    
    November 2024
50. CARCHMAN E, Sanger CB
    Anal cancer prevention: A field in need of scientific Advancement.
    Virology. 2024;602:110323.
    PubMed     Abstract available
    
    
    
51. JIN H, Zhao YR, Huang F, Hong Z, et al
    Vaccinia virus-mediated oncolytic immunotherapy: Emerging strategies for gastrointestinal cancer treatment at dawn.
    Virology. 2024;602:110303.
    PubMed     Abstract available
    
    
    
52. ALI AA, Tabll AA
    Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development.
    Virology. 2024;602:110307.
    PubMed     Abstract available
    
    
    
53. ZHANG J, Pan W, Wang Y, Zhang C, et al
    Corrigendum to "Enhancing vaccine efficacy: Evaluating the superiority of cationic liposome-squalene adjuvant against PCV2 infection" [Virology (2024) 110251].
    Virology. 2024 Nov 7:110271. doi: 10.1016/j.virol.2024.110271.
    PubMed    
    
    
    October 2024
54. ZHANG J, Pan W, Wang Y, Zhang C, et al
    Corrigendum to "Enhancing vaccine efficacy: Evaluating the superiority of cationic liposome-embedded squalene adjuvant against PCV2 infection" [Virol. 600 (2024) 110251].
    Virology. 2024 Oct 21:110263. doi: 10.1016/j.virol.2024.110263.
    PubMed    
    
    
    September 2024
55. RAHARINANTOANINA J, Joffret ML, Bessaud M, Rakoto DAD, et al
    Wide circulation of type 1 vaccine-derived poliovirus strains in clinical specimens from suspected cases of poliomyelitis, their contacts and in wastewater in Madagascar since late 2020.
    Virology. 2024;600:110253.
    PubMed     Abstract available
    
    
    
56. ZHANG J, Pan W, Wang Y, Zhang C, et al
    Enhancing vaccine efficacy: Evaluating the superiority of cationic liposome-embedded squalene adjuvant against PCV2 infection.
    Virology. 2024;600:110251.
    PubMed     Abstract available
    
    
    
57. JANG SO, Lee JH, Chung YJ, Oh HS, et al
    Chimeric adenovirus-based herpes zoster vaccine with the tPA signal peptide elicits a robust T-cell immune response.
    Virology. 2024;600:110243.
    PubMed     Abstract available
    
    
    
58. HERMANN S, Stevens MJA, Sigrist B, Bilic I, et al
    Unveiling the genetic landscape of infectious laryngotracheitis virus in Switzerland: Evidence for vaccine-like and wild-type strains.
    Virology. 2024;600:110217.
    PubMed     Abstract available
    
    
    
59. HUANG WC, Baker WS, Lovell JF, Schein CH, et al
    Displaying alphavirus physicochemical consensus antigens on immunogenic liposomes enhances antibody elicitation in mice.
    Virology. 2024;597:110152.
    PubMed     Abstract available
    
    
    
60. LEI Y, Xu N, Niu C, Chen L, et al
    Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
    Virology. 2024;597:110142.
    PubMed     Abstract available
    
    
    
61. LI S, Tang X, Zhou J, Bian X, et al
    The synergy of recombinant NSP4 and VP4 from porcine rotavirus elicited a strong mucosal response.
    Virology. 2024;597:110130.
    PubMed     Abstract available
    
    
    July 2024
62. MANDVIWALA AS, Huckriede ALW, Arankalle VA, Patil HP, et al
    Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice.
    Virology. 2024;598:110194.
    PubMed     Abstract available
    
    
    
63. HOUTA MH, Hassan KE, Kilany WH, Shany SAS, et al
    Evaluation of different heterologous-homologous vaccine regimens against challenge with GI-23 lineage infectious bronchitis virus.
    Virology. 2024;598:110193.
    PubMed     Abstract available
    
    
    
64. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed     Abstract available
    
    
    June 2024
65. ZHU H, Li X, Li X, Chen H, et al
    Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
    Virology. 2024;597:110162.
    PubMed     Abstract available
    
    
    
66. ZHANG B, Li S, Zhou J, Wang W, et al
    A novel virus-like particles vaccine induces broad immune protective against deltacoronavirus in piglets.
    Virology. 2024;597:110150.
    PubMed     Abstract available
    
    
    
67. KIM J, Villar Z, Jobe O, Rerks-Ngarm S, et al
    Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1.
    Virology. 2024;597:110158.
    PubMed     Abstract available
    
    
    
68. ABDEL-MONEIM AS, Murovska M, Soderlund-Venermo M, Vakharia VN, et al
    WSV2023 - The second meeting of the world society for virology: One health - One world - One virology.
    Virology. 2024;594:110049.
    PubMed     Abstract available
    
    
    
69. HE X, Jiang N, Li Y
    Saccharomyces cerevisiae cells that display norovirus P induce both systemic and mucosal neutralizing antibodies.
    Virology. 2024;594:110034.
    PubMed     Abstract available
    
    
    
70. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed     Abstract available
    
    
    May 2024
71. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed     Abstract available
    
    
    
72. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    PubMed     Abstract available
    
    
    
73. YANG D, Wang X, Yang X, Qi S, et al
    Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus.
    Virology. 2024;596:110113.
    PubMed     Abstract available
    
    
    
74. SHAO J, Liu W, Gao S, Chang H, et al
    A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs.
    Virology. 2024;596:110103.
    PubMed     Abstract available
    
    
    April 2024
75. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    PubMed     Abstract available
    
    
    
76. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    PubMed     Abstract available
    
    
    March 2024
77. AMOSOVA IV, Timoshicheva TA, Kadyrova RA, Zabrodskaya YA, et al
    The investigation of the dynamics of changes in neutralizing antibody titers against type 5 adenovirus in the context of vaccination against a new coronavirus infection.
    Virology. 2024;594:110051.
    PubMed     Abstract available
    
    
    
78. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
    Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
    Virology. 2024;594:110050.
    PubMed     Abstract available
    
    
    October 2023
79. NIU S, Guo Y, Wang X, Wang Z, et al
    Innate immune escape and adaptive immune evasion of African swine fever virus: A review.
    Virology. 2023;587:109878.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum